Lv39
230 积分 2023-06-05 加入
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
6天前
已完结
Navigating the Evolving Landscape of EGFR -Mutated NSCLC
8天前
已完结
TP53 apoptosis biomarkers in breast cancer
9天前
已关闭
Differentiating Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases With Emphasis on Pathological and Molecular Considerations: Recommendations From the International Association for the Study of Lung Cancer Pathology Committee
10天前
已完结
A clinical guide to TP53 mutations in myeloid neoplasms
10天前
已完结
Articles Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial
14天前
已完结
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
14天前
已完结
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
14天前
已完结
Kidney and Survival Outcomes with Semaglutide by CKD Severity in the FLOW Trial
14天前
已关闭
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
14天前
已关闭
皖公网安备34019202002308
